Preserved in Portico This version is not peer-reviewed
The Association Between Presence of Comorbidities and COVID-19 Severity; A Systematic Review and Meta-Analysis
: Received: 20 August 2020 / Approved: 21 August 2020 / Online: 21 August 2020 (07:47:44 CEST)
A peer-reviewed article of this Preprint also exists.
Journal reference: Cerebrovascular Diseases 2021
Results: A total of 6270 individuals were assessed (1615 severe and 4655 non-severe patients). The median age was 63 (95% CI: 49-74) and 47 (95% CI: 19-63) years in the severe and non-severe groups, respectively. Moreover, about 41% of patients had comorbidities. Severity was higher in patients with history of cerebrovascular disease: OR 4.85 (95% CI: 3.11-7.57). The odds of being in severe group increase by 4.81(95% CI: 3.43-6.74) for history of cardiovascular disease (CVD). This was 4.19 (95% CI: 2.84-6.19) for chronic lung disease and 3.18, 95% CI: 2.09-4.82 for cancer .The odds ratio of a diabetes and hypertension were 2.61 (95% CI: 2.02-3.3), and 2.37( 95% CI: 1.80-3.13) respectively.
COVID-19; disease severity; comorbid conditions
MEDICINE & PHARMACOLOGY, General Medical Research
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.